Ligand Reports Third Quarter 2015 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and nine months ended September 30, 2015, and provided an operating forecast and program updates.
Financial highlights for the third quarter of 2015 include:
• Total revenues were $17.7 million and royalty revenues were $9.8 million, an increase of 18% and 30%, respectively, compared with the third quarter of 2014.
Help employers find you! Check out all the jobs and post your resume.
Financial highlights for the third quarter of 2015 include:
• Total revenues were $17.7 million and royalty revenues were $9.8 million, an increase of 18% and 30%, respectively, compared with the third quarter of 2014.
Help employers find you! Check out all the jobs and post your resume.